Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Time for Reperfusion in Acute Pulmonary Embolism

NCT07436702 is registered in ClinicalTrials.gov with Azienda ULSS 8 Berica as lead sponsor.

NCT NCT07436702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07436702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Time for Reperfusion in Acute Pulmonary Embolism
Lead sponsor
Azienda ULSS 8 Berica
Phase
Observational
Overall status
Recruiting
Start date
November 25, 2025
Completion date
October 30, 2026
Enrollment
500 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism (diagnosis), pulmonary embolism acute